Establishing clinical research networks for future infectious disease outbreak responses in Southeast Asia: Report of a workshop on challenges and opportunities

被引:0
|
作者
Han, Su Myat [1 ,2 ]
Mo, Yin [3 ,4 ]
Wang, Lin-Fa [2 ,5 ]
Lye, David C. [1 ,2 ,4 ,6 ,7 ]
Young, Barnaby Edward [1 ,2 ,6 ,7 ]
Paterson, David [3 ,4 ]
Tambyah, Paul Anantharajah [8 ]
Wen, Yeo Tsin [2 ,9 ]
PREPARE Temasek Fdn READI Trials Workshop Participants
机构
[1] Natl Ctr Infect Dis NCID, Singapore, Singapore
[2] Minist Hlth, Programme Res Epidem Preparedness & Response PREPA, Singapore, Singapore
[3] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Adv ID, Singapore, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Infect Dis Translat Res Programme, Singapore, Singapore
[5] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore
[6] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore
[7] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[8] Natl Univ Singapore Hosp, Dept Med, Div Infect Dis, Singapore, Singapore
[9] Woodlands Gen Hosp, Singapore, Singapore
来源
IJID REGIONS | 2025年 / 14卷
基金
英国医学研究理事会;
关键词
Clinical research networks; Southeast Asia; Pandemic preparedness; Disease X; Respiratory infections; Global health; VIRUS;
D O I
10.1016/j.ijregi.2024.100494
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The COVID-19 pandemic highlighted the critical need for well-established clinical research networks capable of rapid response during infectious disease outbreaks. In Southeast Asia, the absence of active research networks at the onset of the COVID-19 contributed to gaps in regional preparedness. This manuscript discusses the challenges and opportunities identified during a regional workshop held in Singapore (February 26 to March 1, 2024), which brought together 130 stakeholders from across the region. The workshop aimed to build consensus on strategies to strengthen existing networks by developing human capacity, overcoming resource limitations, and sustaining collaborative research during inter-pandemic periods. Key challenges identified included the variability in research infrastructure across countries, complex regulatory requirements, and insufficient funding during nonoutbreak periods. Recommendations include the development of standardized research protocols, the creation of a regional data sharing platform, and fostering sustained collaboration to ensure these networks remain functional and responsive. Addressing these gaps is critical for enhancing Southeast Asia's capacity to conduct high-quality clinical trials and effectively respond to future infectious disease outbreaks.
引用
收藏
页数:6
相关论文
empty
未找到相关数据